8
Jan. 4, 2021
With an extensive scientific background in neurodegeneration, and especially in Amyotrophic Lateral Sclerosis (ALS), Kim is driven to move safe and effective therapies to people with ALS or with other rare diseases across the globe. After two postdocs in academia, Kim set out to provide science consultancy to biotech, academia, and patient organizations. In addition, as a career coach, she feels strongly about inspiring and empowering academic scientists to obtain the careers that they want, eit...